| MR Imaging of Brain: Multiple Sclerosis Room A108 |
| 16:00 228. Young Investigator Awards Finalist: Magnetization Transfer and Multi-Component T2 Measurements with Histopathologic Correlation in an Experimental Model of Multiple Sclerosis, P.J. Gareau, B.K. Rutt, S.J. Karlik and J.R. Mitchell, John P. Robarts Research Institute and London Health Sciences Center, London, Ontario, Canada. |
| 16:20 229. Statistical Analysis of MTR Histograms in Multiple Sclerosis, J. Dehmeshki, D.H. Miller and P.S. Tofts, University College London, London, UK. |
| 16:32 230. Brain and Cord Magnetization Transfer Imaging Histograms in Multiple Sclerosis Patients, M. Rovaris, M. Bozzali, G. Santuccio, M.P. Sormani, G. Comi and M. Filippi, H. San Raffaele, Milan, Italy. |
| 16:44 231. Multiple Sclerosis Functional Composite Related to MRI Parameters, N.F. Kalkers, V. de Groot, R.H.C. Lazeron, M.A.A. van Walderveen, J.J. Bot, B.M.J. Uitdehaag, C.H. Polman and F. Barkhof, University Hospital 'Vrije Universiteit', Amsterdam, The Netherlands. |
| 16:56 232. Magnetization Transfer Ratio and Mean Diffusivity of Normal-Appearing White and Gray Matter from Patients with MS, M. Cercignani, M. Bozzali, G. Iannucci, G. Comi and M. Filippi, University of Milan, Milan, Italy. |
| 17:08 233. Interferon b-1b and Intravenous Methylprednisolone Enhance Lesion Recovery In Relapsing Remitting Multiple Sclerosis (RRMS) Patients, N. Richert, J. Ostuni, C. Bash, T. Leist, H. McFarland and J.A. Frank, National Institutes of Health, Bethesda, MD, USA. |
| 17:20 234. Interferon-b-1b Reduces Development of Black Holes in Secondary Progressive MS, F. Barkhof, J.H.T.M. van Waesberghe, D. Hahn, M. Filippi, D.H. Miller, T. Yousry, L. Kappos and C.H. Polman, Vrije Universiteit Academic Hospital, Amsterdam, The Netherlands; San Raffaele Hospital, Milan, Italy; Klinikum Grosshadern, Munich, Germany; Institute of Neurology, London, UK; Ludwig Maximillan Hospital, Wurzburg, Germany and Kantonsspital, Basel, Switzerland. |
| 17:32 235. Quantitative T1 Mapping in Multiple Sclerosis Pre and Post Gd CR Administration, W.D. Rooney, F. Telang, L. Krupp, P. Coyle and C.S. Springer, Brookhaven National Laboratory, Upton, NY, USA and State University of New York, Stony Brook NY, USA. |
| 17:44 236. The Effect of Gadolinium Enhancing Lesions on Whole Brain Atrophy in Relapsing-Remitting Multiple Sclerosis, A.M. Saindane, Y. Ge, J.K. Udupa and R.I. Grossman, University of Pennsylvania Medical Center, Philadelphia, PA, USA. |